Feedback
Alpha-Galactosidase, Serum
2003204
Ordering Recommendation

Enzyme testing is reliable for diagnosing Fabry disease in males; it does not detect carriers. For carrier status, DNA analysis is recommended.

Mnemonic
A GALACTO
Methodology
Quantitative Fluorometry
Performed
Varies
Reported
15-22 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Plain Red or Serum Separator Tube (SST). 
Specimen Preparation
Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 0.2 mL) 
Storage/Transport Temperature
Frozen. 
Unacceptable Conditions
Thawed specimens. 
Remarks
 
Stability
Ambient: Unacceptable; Refrigerated: 24 hours; Frozen: 2 weeks 
Reference Interval
By report
Interpretive Data


Note
Results for this assay are not useful for carrier determination. Carriers usually have levels in the normal range.
CPT Code(s)
82657
Components
Component Test Code*Component Chart NameLOINC
2003206Alpha-Galactosidase, Interpretation59462-2
2003211Alpha-Galactosidase, Review59465-5
2003212Alpha-Galactosidase, Serum1813-5
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Anderson Fabry Disease (Alpha Galactosidase, Serum)
  • GLA Deficiency (Alpha Galactosidase, Serum)
  • Soft AGAS (Alpha Galactosidase, Serum)

Performed at Mayo